The portfolio maintains a cost advantage over competitors, priced within the lowest fee quintile among peers.
SPDR® S&P Biotech ETF XBI
Morningstar’s Analysis XBI
Will XBI outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 12.8
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Alpine Immune Sciences Inc | 1.94 | 123.4 Mil | Healthcare |
Revolution Medicines Inc Ordinary Shares | 1.28 | 81.7 Mil | Healthcare |
Exelixis Inc | 1.24 | 79.1 Mil | Healthcare |
Moderna Inc | 1.21 | 76.9 Mil | Healthcare |
Natera Inc | 1.20 | 76.5 Mil | Healthcare |
Sarepta Therapeutics Inc | 1.20 | 76.4 Mil | Healthcare |
Cerevel Therapeutics Holdings Inc Ordinary Shares | 1.19 | 76.1 Mil | Healthcare |
Roivant Sciences Ltd Ordinary Shares | 1.19 | 76.0 Mil | Healthcare |
Crinetics Pharmaceuticals Inc | 1.17 | 74.6 Mil | Healthcare |
Neurocrine Biosciences Inc | 1.16 | 73.8 Mil | Healthcare |